Virus therapy targets superbug in transplant patients
Disease control
Recruiting now
This study tests a new treatment called SNIPR001, which uses specially designed viruses to kill a type of antibiotic-resistant E. coli bacteria. The trial includes 24 adults with blood cancer who are scheduled for a stem cell transplant and already carry these resistant bacteria.…
Phase: PHASE1, PHASE2 • Sponsor: SNIPR Biome Aps. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC